« Back to Record
De Backer, D. (2007). Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis. Drug safety, 30(11), 995-1010.
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/83195



